European Sold Production of Antisera and Vaccines by Country

The European market for sold production of antisera and vaccines in 2023 showed considerable variation by country. Ireland led the market with a significant value of 22.067 billion euros, followed by Belgium at 5.1239 billion euros. Both countries experienced substantial year-on-year growth, with Belgium showing an impressive 79.56% increase, while Ireland grew by 5.81%. In contrast, France and Germany saw declines of 7.99% and 0.34%, respectively. Emerging markets like Italy and Hungary displayed moderate growth, while the United Kingdom and Spain experienced minor contractions. Smaller contributors such as Denmark, Croatia, and Romania showed notable declines, while Finland, Austria, and Lithuania maintained stable production values.

Future trends to watch for include the anticipated continued dominance of Ireland and Belgium in the market, driven by their robust biopharmaceutical industries. With fluctuating geopolitical conditions and evolving healthcare priorities, countries like Sweden, which saw a substantial increase of 22.92%, and Italy, also showing growth, may become more significant players. Additionally, technological advancements and increased investment in vaccine research and development may spur growth in currently smaller markets, potentially altering the European landscape for antisera and vaccine production.

Top countries in Sold Production of Antisera and Vaccines by Country

# 10 Countries Euros Last Year YoY 5-years CAGR
1 1 Ireland 22,067,000,000 2023 +6.08% +5.81% View data
2 2 Belgium 5,123,900,000 2023 +0.089% +79.56% View data
3 3 France 2,600,400,000 2023 +2.55% -7.99% View data
4 4 Germany 2,205,800,000 2023 +2.13% -0.34% View data
5 5 Sweden 1,899,000,000 2023 +13.55% +22.92% View data
6 6 United Kingdom 864,120,000 2023 +2.08% -2.4% View data
7 7 Spain 769,650,000 2023 +3.34% -2.69% View data
8 8 Italy 533,620,000 2023 +1.78% +8.02% View data
9 9 Hungary 124,220,000 2023 +2.54% +4.19% View data
10 10 Finland 64,984,000 2023 +6.48% +1.66% View data

Top Countries about Immunology